صفحه 1:
صفحه 2:
disorder ورزر
O6O-0) (
°Wypersvwsin (DE6M-10)
صفحه 3:
صفحه 4:
Oke & kypersvwata?
- Cxcessve doyioe sleepers coupled
wi sleep oP excessive turdioa.
صفحه 5:
Hypersomnia
Narcolepsy with Cataplexy
Narcolepsy without Cataplexy
Narcolepsy due to Medical Condition
Idiopathic Hypersomnia with Long Sleep Time
Idiopathic Hypersomnia without Long SI. Time
Behaviorally Induced Insufficient Sleep Syn
Hypersomnia due to Medical Condition
Hypersomnia due to Drug/ Substance
هم كم تع حم a ا el
صفحه 6:
۱ sleephess despite oo steey perid best
tt best “Phos
0. periods oP heey Ahi sore ike
©. Prooned sleep eperde wore Ok worestvraive
۵.6 سا ٩ eves per weeks ot beet OD مكدب
0. 45 wh beter expkiced cower slop deorter or u porwowoe
للك oirbutcble to physiologic سوه و خن اه
C. Ovexstay weotd ond wedrd doorders de ot adequately expla
|
ا
صفحه 7:
۰
۰
۰
ده
صفحه 8:
لاس
Pro طلسم Se
a
صفحه 9:
Gpwpivws
* Dke woe sywpiow ve hppersownsic is
Exupssive dovitwe sleepicess (ECOG), or
تاره رد لت رما kes poourred
Por ut beast 9 wouths prior to deposi
صفحه 10:
up to the sorcicgy رما رال
couPused, cocwbuive, or otic حو وود
-مروصاك Dhie poloaged kepuired oP erases ut the
wwe trowsiize is oPtea nePenced ty us steep toerta (i.e,
skep dambkeudss).
behavior way be very tcappropricie, *
وه له سر وا ماو رح wewory *
مها موی ۰
و وه و و و
صفحه 11:
* Ovwestoraive sleep
© subset oP iodviduas wi hypersoworleare ۴
وا مورا disorder have u Pacnily history oP
عم چاه بارش وولو لور سور
امه( مصجورو ع لجح peripherd
phewweun)
صفحه 12:
a S%AO% oP لش who ooceul اه ها
© egud ft woes und همه
صفحه 13:
Putkoiogy
* Gubvonivd انح wediatocy steep-woke
Puontivas disrupted
5 (sorcolepsy ood (letce-Levia Gyadrowe)
٠ OR1 shows icstabiliy oP corticd eters ict
fedviduds wits Coysiive Phactuctizas
صفحه 14:
© 2001 Sinauer Associates, Inc.
Suprachiasmatic
nucleus
Lateral
geniculate —__
nucleus
retina
صفحه 15:
085 جلك دمح "صصص Oudtew
— ant oP kypotkotrus
— Oxerage disrupts مكايو
صفحه 16:
صفحه 17:
Oinguosis
© "Dke severiy of dapioe واه weeds ty be
quoditied by subjeviive svder (at trast he
CGpwortk Cleepiess Ova) ood objective tests
0 اح دص
ا سب رون زر
صفحه 18:
سح 60 تا سامت مه اد
ساموت تمد مسا ای مرت
ا ا ا
Prckary owes we roe
Ow wots coarse & ber اه صر مس ای ,تا اجه امن
اه رام سا obey doorcers (ec, brethinrrekted okey cboorder) ny worsen:
Se
صفحه 19:
و هو وه وه وه و © و هو و
صفحه 20:
موه عنورلیط)
Oude
Cady adblesorwe
© 25
سوج ج ورياك
صفحه 21:
* موی ond reve wih طلست ٩ وا مه
1
Drecivedt wil OOP مشاه ع ۴
Georatey to وا وم ۴
صفحه 22:
disorders (dudoy a depressive epirde), ond wine
٠ برعةاتحقههم جمدل مطل لصتواص دوصوو وتانج عروذا جاور إن
relied to واه کات متمطلج لإ
QOeundeyeverdive vocntiivas, suck os @lzhekver's
ا ا ا diseuse, ood wutiple syetew
صفحه 23:
صفحه 24:
(Broie uctiviy is ;weusured us electric wuveEs
صفحه 25:
صفحه 26:
۱ حعب DP brat waves Exist uray
Relaxed / Waking
نی Ho Matta,
Stage 1 Light Sleep
WAAL earn wart attain
Stage 2 Light Sleep
Deep Sleep
REM / Dreaming
صفحه 27:
صفحه 28:
os
الهم هاه
صفحه 29:
صفحه 30:
3
1
۳ روت بو لت عمج من ood way
بسا userpadied by motaplexy, 3 total loss oF
| ادس
4 عم 9 و لت 9 بسا woos
Dovvkpsy — what & 17
- 0 steep doorder where people experi
ای لین okep امي dura he
day where 9 persra aay op Brow bern
cache sirach iio REO steep.
صفحه 31:
Se
۳
۷
له پوت نوی منت مج نوت لا -
امه موی روا sony be cmoexupmied
( امه ممهجم) سا طمصی و
Dovvkpsy — what & 17
- 0 steep doorder where people experi
ای لین okep امي dura he
day where 9 persra aay op Brow bern
cache sirach iio REO steep.
صفحه 32:
Nocturnal sleep polysomnography showing
rapid eye movement (REM) sleep latency
less than or equal to 15 minutes, or a multiple
sleep latency test showing a
mean sleep latency less than or equal to 8
minutes and two or more sleep-onset
REM periods.
صفحه 33:
Ourcolepsy
Dorcckpsy wikout بوصاصكد
bat wit Kypooretioe dePivicagy
bow CGP hyporretiae levels
posite pos waryraphy
صفحه 34:
۶ جات بط و اش تون
eee ee
Rare subppe °
صفحه 35:
cerebetar dtoxta , ° مج توح @uvsowd
بوععامص هه , عدص وداه
65 90 000 ده (4عس6) *
bote poset © QO-PO peas *
صفحه 36:
ال
۰ «وروطد ج10 is Por carcplepsy thot develops ما بمو صعجد
ولو لین hot pause iPevtizus
* (es, Ohppk's deeue, sarcodbsts), traumatic, or toon
خام مصاص وجل
۰ مج اما
صفحه 37:
صفحه 38:
Oucolepsy: OGLT, GOREOs
*— Sleep Latency
im REM Latency
1
2 3 4 5
Steep (Nap) Periods
Figure 35. ‘The results of L.I’s Multiple Sleep Latency Test.
صفحه 39:
هو ولمم(
cloud food
foodland
food coma
carb coma is a normal state of drowsiness or
lassitude following a meal
Postprandial somnolence has two components: a *
general state of low energy related to activation of
the in response to
mass in thegastrointestinal tract, and a specific _
‘state of sleepiness by and 1
related to the rate at which glucose enters
the bloodstream and its downstream effects on
.central nervous system amino acid transport in the
و هو و و
صفحه 40:
Ayporretalorexta hypotheses
6 sll ise to blood qucvse thot صفحدج Per o wed ts seused by
سدع ادوس bsieral hypoilsotocm.
° | Dheer crexic-expressioy ururves upper to be hyperpolorised
(hibited) by 0 qhucose-ortivated ما ۱۳ اوه نی
مس ty thea redoe vuln Prone عفج هخسن ceo
pakuays oP ike امه ماه لاه عمط تسه
bran, thus deoreusiog the uviviy oP those puwapys, ord
صفحه 41:
tcp ecient) سمل ماس ممجومل(؟)
سس سس میت 9
* محا و( oP the sleep ruck to 3 rack مصممو oP this strc
مه له موس و جج وه له تسه ۰
رل ۰ بلج ,اوه ماه بط of مرا م6
مخت و وم لیلج سوه مود
صفحه 42:
Crioay hypersowain wire
صصص disorders
۱ Dorie
dseuse; Oieworun-Pick سره لوصو
ی دا ام سس 5
جاح ,وم ٩0 بسن مسع) 9000
( راو و por ص
صفحه 43:
صفحه 44:
رع) مد اه توص ون مرسمه
۱۱ jobs) thot leads t7 Excessive
Ours Gleepiness (COG) und و derrewed
devel oP واه
صفحه 45:
صس هی Oinostic
مت صلج جروسته له روطمو موم وولو( ۰
اک
50
laboraipries). توصب جا بالیس 1 مه راد ای ۰
رسمه له ره باطلا ج وا اون
oPRevted induiduaks marry WL- <و 6990
0۳۵909
صفحه 46:
۱
۱ CO%-OD% oF elk enpericare vid hues hick
Pier auch اسر سم
Orbison orl vad تا نت رزوی و تسوت مه وم (REO sleep bebo chore
خرس امس واه بو نس موه تمه وت ما wis strom or oboe حرط
Darker rst ارو
جه
Obeoty te comm
Dpcturud sleey deruptoa wits Proqurct loan or oho aurcheraienp tr coer od
۳ لد سا موی
جر اه بح ی تحت تحت fhe وا sleepy or Pol asker مسرت رو لش
و لوا سا اج iro oh اه بو (Durant extort, amish
طسو مس
۰
۰
۰
0
۰
صفحه 47:
۰ Ourcrtepsy-catuptexy oPPevis 0.0C%-
OG eet tee eee pepcimet cee
pointes
* Ourolepsy PP ets bois yeuders, wits possibly a
shh! wake prepoodercare
صفحه 48:
Octopleny te x dbrupl teeoporany boos oP vokvaiery اج
۱ such os
foughier, pleasure, omer, or exciewect.
Octaplexy vores wheo o persvo expenieures ام و
هب ره و لو و مج - مود trip
اجه و ذا تا ر(موومه) مه مه تن ر(امصوه)
stvutativg trade too very rapid loss oF uohuctary wustte cocirdl
ها ام ce eed te
05-0
صفحه 49:
صفحه 50:
117 م ا ب ام ل ل ل دوب
ا
بححطج مهم لجن وتات سر
2 a يي a
| ج لحاس مت لش ,اس
ieee ند سس سس له
و رو رارف Ake Prot wands, cotorkemy way be
و
“foxy chided ond oder اه رطس لب develo موی 2 ae
probes sroretory to vleepiare oxlor vichtioe veep terriers. Derbkrrd
ho kay wat ay سس سس لس
رای سوه زلوت نا و ببس Prexprmey |
لام مهد يدم
صفحه 51:
مها ماه RECO رما وجاك و اس
در« رس ی اف وی ابو یت
سوه
طل راتلس) Crap © sirepiooerd thro Pein, icPuecza
OUI) rer cares cre Meh cr oF A
ل هه See سس
۳ دم ال سم
صفحه 52:
صفحه 53:
(courpoysteercosts)
Al. Oks. Gkep Ded. (A)
Figure 1—Sagital T1-weighted magnetic resonance image showing a cys-
ticerci lesion in the left lateral hypothalamus. An invaginated scolex can be OOS, p. Fd.
seen within the cyst (arrow).
صفحه 54:
Cuhure-Retoted Otaquostic ues
له io woop مت عم اه أن 40 *
موه OPriccd ©
صفحه 55:
اش و طاسب له را) ۰
° thot 0 ا
See ee pilot) جح نا ۱
۰ أ روطمممه عا ون a
Pa eee rarely bron
واه مود
gaa ل اا
thewselves or vers 7 چا وله لو ما
صفحه 56:
م0۴۳۴
* pbesity
۰ Qupr depressive disorder
كد 0 ل ads in Bed
OGL results ore wost ا ع لاه ears
dissociation betwerd subjerive ood objective
dleepiness, us weosured by the wean sleep hiewy
هذا يحل DGLT
صفحه 57:
ع اتح دورو راو ره
Reéprodtction rights obtainable from
ww. CartoonStock.com
“| also have trouble sleeping. | don’t
understand why. No one | talk to seems
to have any trouble falling asleep.”
صفحه 58:
سا بو تت 0 Es a 0
disorder همه و مور
له اه مس رو
۱ sleep-verrt
1 hick rewuict
سر
صفحه 59:
OOx
موق *
وهی موه cotoplexy لاه وه وا ۰
صفحه 60:
و66
رات مورا لش ۲و وحم سا ول ۰
cate aa a 1 ارهز
۰ IP cotoplexy ts presed, the choice should Pirst
weve thot these sywpiows ore لو ۲
wormlepsy bePore وه و ممص لومت
diagaosts oP schizophrecia.
صفحه 61:
۱
depressive, und او و لت ,لسوت مت
رسای اش وی
* Ieoreused body ware index or besiy
° deep upoeu should be pousidered
صفحه 62:
تسه عه وطلوهن لب بومعامصه 0
Oop
صفحه 63:
"No wonder you have insomnia...
lying there awake all night."
صفحه 64:
Oke or te cases of سوه #
- جا برو صاصم a rare disorder comin,
fa less thet 1% oF people
sorted couse is chore, way be ب
Oke & the best reamed Por
رطس
ول سس وا ولج -
رسد
dap ty prevedt the vet oP RED
اد
- روا و رما whick lows Por a
اه سوه لاه لمح
وه سول
©Qignal dist,
Reproduction nghts obtainable from
sino CartoonStocl.com
"On your application it says you
have narcolepsy. What is that?”
صفحه 65:
Presto hypersvocta
و ملس Bleokal cad Cob Pere
مه : لاور تلو(
15 روط | REO seep suppresskny dane (Butdepresscnis )
Qed Por extern
تا مهو
۳ وت
موی بط Onorbrate فطع
ار موی وا وی لگ مه لوط
ec 08 هد هي
صفحه 66:
Provicd) ( ا
pected alpha (lo odeecerdic aypcist, to idiopathic شنم و
ای له جوا
٠ لوب مساق und drowsiness were سوم رتاو
۱ kes co exceed beuePiltel rato te idiopotie
Aupersvwoid
٠ Okeu cotupleniy episodes were unt totaly suppressed the
نوا هه موه dose oP Olowipravice wos sucess Pl it
۱ thew.
صفحه 67:
daily
صفحه 68:
© rood ral so POO upproved drug thot iso
purer versie oF the ucive topcoat ict Doda.
صفحه 69:
٠ ام لو بط سا موی لوق ۵۳۷
hydrombuiyric acid (BLO)
(todo wikdeawval ord depeedecre
صفحه 70:
یه
تم ت۱۷
و هو و و و هو و
Sleep Awake Disorders
• Hypersomnolence disorder
( DSM-V)
• Hypersomnia (DSM-IV)
Definition
• In the 5th edition of the Diagnostic and Statistical
Manual of Mental Disorders, published in May
2013, hypersomnia appears under sleepwake disorders as hypersomnolence, of
which there are several subtypes
What is hypersomnia?
- Excessive daytime sleepiness coupled
with sleep of excessive duration.
• Self-reported excessive sleepiness despite a main sleep period lasting
at least 7 hours
• 1. Recurrent periods of sleep within same time
• 2. Prolonged sleep episode more 9 h nonrestorative
• 3. Difficulty being fully awake after abrupt awakening
• B. At least 3 times per weeks at least 3 months
• C. Significant distress or impairment social occupational
• D. Is not better explained another sleep disorder or a parasomnia
• E. Not attributable to physiological effects of a substance
• F. Coexisting mental and medical disorders do not adequately explain
complaint of hypersomnia
Specify
•
•
•
•
Mental disorder including substance use disorder
With medical condition
With another sleep disorder
•
•
•
Acute : Duration of less than 1 month
Sub acute : 1-3 months
Persistent : more than 3 months
•
•
•
•
Mild : Difficulty maintaining daytime alertness 1-2 days/week
Moderate : 3-4 days/week
Severe : 5-7 days/week
Diagnostic Features
broad diagnostic term
symptoms of excessive quantity of sleep (e.g.,
extended nocturnal sleep or involuntary daytime sleep)
Deteriorated quality of wakefulness (i.e., sleep
propensity during wakefulness as shown by
difficulty awakening
inability to remain awake when required)
sleep inertia (i.e., a period of impaired
performance reduced vigilance following
awakening from the regular sleep episode or from
a nap)
Symptoms
• The main symptom of hypersomnia is excessiv
e daytime sleepiness (EDS), or prolonged
nighttime sleep, which has occurred for at least
3 months prior to diagnosis
•
•
•
•
•
fall asleep quickly
good sleep efficiency (>90%)
difficulty waking up in the morning
sometimes confused, combative, or ataxic
This prolonged impairment of alertness at the sleepwake transition is often referred to as sleep inertia (i.e.,
sleep drunkenness).
• behavior may be very inappropriate,
• memory deficits, disorientation in time and space
• automatic behavior
Associated Features Supporting Diagnosis
• Nonrestorative sleep
A subset of individuals with hypersomnolence •
disorder have a family history of hypersomnolence
• autonomic nervous system dysfunction, including
recurrent vascular-type headaches, reactivity of the
peripheral vascular system (Raynaud's
phenomenon)
• fainting
Prevalence
• 5%-10% of individuals who consult in sleep
disorders clinics with complaints of daytime
sleepiness are diagnosed as having
hypersomnolence disorder
• 1% of the European and U.S. general
population has episodes of sleep Inertia
• equal in males and females.
Pathology
• Subcortical circuits mediating sleep-wake
functions disrupted
• (narcolepsy and Kleine-Levin Syndrome)
• MRI shows instability of cortical networks in
individuals with Cognitive flactuations
Retinohypothalamic pathway
Suprachiasmatic Nucleus
– Part of hypothalamus
– Damage disrupts rhythm.
Diagnosis
• "The severity of daytime sleepiness needs to be
quantified by subjective scales (at least the Epwor
th Sleepiness Scale) and objective tests such as
the multiple sleep latency test (MSLT)." The
Stanford sleepiness scale (SSS) is another
frequently-used subjective measurement of
sleepines
Development and Course
•
•
•
persistent course
sleep episodes can last up to 20 hours
average nighttime sleep duration is around 9 hours
Awakenings are very difficult and accompanied by sleep inertia episodes in nearly 40% of cases
•
Pediatric cases are rare
For most individuals, the course is then persistent and stable, unless treatment is initiated
•
The development of other sleep disorders (e.g., breathing-related sleep disorder) may worsen
the degree of sleepiness.
• hyperactivity may be one of the presenting signs of daytime sleepiness in
• children
Risk and Prognostic Factors
•
•
•
•
•
•
•
•
•
•
Environmental
increased temporarily by psychological stress
and alcohol use
infectious
about 10% of cases
Viral infections, such as HIV pneumonia,
mononucleosis, and Guillain-Barre syndrome
6-18 months following a head trauma
Genetic and physiological
Hypersomnolence may be familial, with an autosomal
dominant
Kleine-Levine syndrome
•
•
•
•
•
•
•
Recurrent hypersomnia
Male
Early adolescence
Voracious eating
Hypersexuality
Disinhibition and aggression
Extreme sleepiness ( 18-20 hour sleep period)
Menstrual-related hypersomnia
Symptoms last 1 week and resolve with menstruation •
Treatment with OCP is effective •
Secondary to hormone imbalance •
•
Menstrual-related hypersomnia •
Symptoms last 1 week and resolve with menstruation •
Treatment with OCP is effective •
Secondary to hormone imbalance •
Comorbidity
• Associated with depressive disorders, bipolar
disorders (during a depressive episode), and major
depressive disorder, with seasonal pattern
• at risk for substance-related disorders, particularly
related to self-medication with stimulants
• Neurodegenerative conditions, such as Alzheimer's
disease, Parkinson's disease, and multiple system
atrophy
Brain activity is measured as electric waves
Different types of brain waves exist during
our sleep cycle
•
•
•
•
•
•
All mammals and birds sleep. Fish, reptiles & amphibians have periods of inactivity too
- Large species differences in sleep: Not related to body size/ temperature
Little/no Effect of exercise on sleep duration in humans (Youngstedt & Kline, 2006
Sloths hardly move, yet need 20 hrs/day
Lions can do little else but sleep
For 2 days after a kill
•
•
•
•
•
•
•
•
•
•
Mammal
Hrs of sleep/day
Giant Sloth
Tree Shrew
Cat, Hamster
Mouse, rat, squirrel
Hedgehog
Humans, rabbit, pig
Cow, Goat, Elephant
Horse, Roe deer
20
15
14
13
10
8
3
2
Long sleeper syndrome
•
•
•
•
•
•
2% of the population
people suffering from this kind of syndrome are in need of more sleep compared to the
conventional sleeping patterns of normal individuals.
M>F
ten to twelve hours
no other symptoms
Sleep pattern and PSG are Normal
Narcolepsy
Narcolepsy – what is it?
- A sleep disorder where people experience
sudden uncontrollable sleep attacks during the
day where a person may go from being
awake straight into REM sleep.
-This can occur without any warning and may
be accompanied by cataplexy, a total loss of
muscle tone (causing collapse).
-At least 3 times/week in 3 past months
Narcolepsy – what is it?
- A sleep disorder where people experience
sudden uncontrollable sleep attacks during the
day where a person may go from being
awake straight into REM sleep.
- This can occur without any warning and
may be accompanied by cataplexy, a total loss
of muscle tone (causing collapse).
Nocturnal sleep polysomnography showing
rapid eye movement (REM) sleep latency
less than or equal to 15 minutes, or a multiple
sleep latency test showing a
mean sleep latency less than or equal to 8
minutes and two or more sleep-onset
REM periods.
Narcolepsy
Narcolepsy without cataplexy
but with hypocretine deficiency
Low CSF hypocretine levels
positive polysomnography
Classic form
Narcolepsy with cataplexy but without
hypocretine deficiency
•
Rare subtype •
MSLT •
Hypocretine csf Normal •
•
Autosomal dominant cerebellar ataxia , •
deafness , narcolepsy
•
Exone 21 DNA (Cystine -5) Mutation •
Late onset : 30-40 years •
Narcolepsy secondary to another medical condition:
• This subtype is for narcolepsy that develops secondary to
medical conditions that cause infectious
• (e.g., Whipple’s disease, sarcoidosis), traumatic, or tumoral
destruction of
• hypocretin neurons.
Narcolepsy: MSLT, SOREMs
Postprandial somnolence
•
•
•
•
cloud food
foodland
food coma
carb coma is a normal state of drowsiness or lassitud
e following a meal
Postprandial somnolence has two components: a •
general state of low energy related to activation of
the parasympathetic nervous system in response to
mass in thegastrointestinal tract, and a specific state
of sleepiness by hormonal and neurochemical
changes related to the rate at which glucose enters
the bloodstream and its downstream effects on amino
.central nervous system acid transport in the
Hypocretin/orexin hypothesis
•
small rise in blood glucose that occurs after a meal is sensed by
glucose-inhibited neurons in the lateral hypothalamus.
• These orexin-expressing neurons appear to be hyperpolarised
(inhibited) by a glucose-activated potassium channel. This inhibition
is hypothesized to then reduce output from orexigenic neurons to a
mineregic,cholinergic, and glutamatergic arousal pathways of the
brain, thus decreasing the activity of those pathways, and
therefore brain arousal.
Sleeping sickness (disambiguation)
• African trypanosomiasis
• Disruption of the sleep cycle is a leading symptom of this stage
• Infected individuals experience a disorganized and fragmented
24-hour rhythm of the sleep-wake cycle, resulting in daytime
sleep episodes and nighttime periods of wakefulness
Primary hypersomnia mimics
genetic disorders
• Prader-Willi syndrome; Norrie
disease; Niemann–Pick disease, and myotonic
dystrophy).
• myotonic dystrophy is often associated with
SOREMPs (sleep onset REM periods, such
as occur in narcolepsy)
Primary hypersomnia mimics
Neurological disorder
Brain tumors; stroke-provoking lesions; and •
dysfunction in the thalamus, hypothalamus,
or brainstem. Also, neurodegenerative conditions
such as Alzheimer's disease, Parkinson's
disease, or multiple system atrophy are
frequently associated with hypersomnia
Behaviorally-induced Insufficient Sleep Syndrome
Unintentional chronic restriction of sleep (e.g., by
working two jobs) that leads to Excessive
Daytime Sleepiness (EDS) and a decreased
.level of alertness
The most prevalent cause of EDS and
daytime fatigue
Diagnostic feature
• Narcolepsy-cataplexy nearly always results from
the loss of hypothalamic hypocretin
• (orexin)-producing cells, causing hypocretin
deficiency (less than or equal to one-third of
• control values, or 110 pg/mL in most laboratories).
Cell loss is likely autoimmune, and approximately
99% of affected individuals carry HLADQBl*06:02
Associated Features Supporting Diagnosis
•
•
•
•
•
•
•
•
•
•
•
•
When sleepiness is severe, automatic behaviors may occur
Approximately 20%-60% of individuals experience vivid hypnagogic hallucinations
hypnopompic hallucinations just after awakening
Nightmares and vivid dreaming are also frequent in narcolepsy, as is REM sleep behavior disorder
However, many normal sleepers also report sleep paralysis, especially with stress or sleep deprivation
Nocturnal eating may occur
Obesity is common
Nocturnal sleep disruption with frequent long or short awakenings is common and
can be disabling.
Individuals may appear sleepy or fall asleep in the waiting area or during clinical examination.
During cataplexy, individuals may slump in a chair and have slurred speech or
drooping eyelids
Prevalence
• Narcolepsy-cataplexy affects 0.02%0.04% of the general population in most
countries
• Narcolepsy affects both genders, with possibly a
slight male preponderance
Cataplexy is an abrupt temporary loss of voluntary muscular
function and tone, evoked by an emotional stimulus such as
laughter, pleasure, anger, or excitement.
Cataplexy occurs when a person experiences an emotional
stimulation - hearing a good joke (laughter), taking a trip
(excitement), having an argument (anger), being in a crowded
store (stress)
stimulation leads to a very rapid loss of voluntary muscle control
- often the person will immediately collapse as a result. The
collapse occurs because the person can no longer control their
leg muscles to remain standing
Development and Course
•
•
•
•
Onset is typically in children and adolescents/young adults but rarely in older adults
Two peaks of onset are suggested, at ages 15-25 years and ages 30-35 years
Abrupt onset in young, prepubescent children can be associated
with obesity and premature puberty
•
•
•
In 90% of cases, the first symptom to manifest is sleepiness or increased sleep, followed
by cataplexy
Sleepiness, hypnagogic hallucinations, vivid dreaming, and REM sleep behavior disorder (excessive
movements during REM sleep) are early symptoms
In the first months, cataplexy may be atypical, especially in
Children
Young children and adolescents with narcolepsy often develop aggression or behavioral
problems secondary to sleepiness and/or nighttime sleep disruption. Workload and
social pressure increase through high school and college, reducing available sleep time at
Night
Pregnancy does not seem to modify symptoms consistently
•
•
•
•
•
•
•
Risk and Prognostic Factors
• Temperamental
• Parasomnias, such as sleepwalking, bruxism, REM sleep behavior
disorder, and enuresis, may be more common in individuals who develop
narcolepsy
• Environmental
• Group A streptococcal throat infection, influenza (notably pandemic
• HlNl 2009), or other winter infections are likely triggers of the autoimmune
process, producing
• narcolepsy a few months later. Head trauma and abrupt changes in sleepwake patterns (e.g., job changes, stress) may be additional triggers.
• Genetic and physiological
• Monozygotic twins are 25%-32% concordant for narcolepsy
SCN
clock
DA (+)
+/-
Orexin /
Hypocretin
Histam.
(+)
5HT
(+)
NA
(+)
Monoamine Con
by Hypocretin
Worm in
lateral
hypothalamus
causing
narcolepsy.
(neurocysticercosis)
J. Clin. Sleep Med. 1(1)
2005, p. 41.
Culture-Related Diagnostic issues
• In all ethnic groups and in many cultures
• African Americans
Functional Consequences of Narcolepsy
• Driving and working are impaired
• that place themselves (e.g., working with machinery)
or others (e.g., bus driver, pilot) in danger
• Once the narcolepsy is controlled with therapy,
patients can usually drive, although rarely long
distances alone
• Untreated individuals are also at risk for social
isolation and accidental injury to themselves or others
Differential Diagnosis
• Sleep apnea syndromes
• obesity
• Major depressive disorder
• Cataplexy is not present in depression. The
MSLT results are most often normal, and there is
dissociation between subjective and objective
sleepiness, as measured by the mean sleep latency
during the MSLT
.
Conversion disorder (functional neurological symptom disorder).
• such as long-lasting cataplexy or unusual triggers, may be
present in conversion disorder
• may report sleeping and dreaming,
• MSLT does not show the characteristic sleep-onset
REM period
• Full-blown, long-lasting pseudocataplexy may occur
during consultation, allowing the examining
• physician enough time to verify reflexes, which remain
intact
DDx
• Seizures
• In young children, cataplexy can be misdiagnosed
as seizures
• Seizures are not triggered by emotions, the trigger
is not usually laughing or Joking
• During a seizure, individuals are more likely to hurt
themselves when falling Seizures
• characterized by isolated atonia are rarely seen in
isolation of other seizures, and they also have
signatures on electroencephalogram
Schizophrenia
• In the presence of vivid hypnagogic hallucinations,
individuals may think these experiences are real a
feature that suggests schizophrenia
with stimulant treatment, persecutory delusions may
develop
• If cataplexy is present, the clinician should first
assume that these symptoms are secondary to
narcolepsy before considering a co-occurring
diagnosis of schizophrenia.
Comorbidity
• Narcolepsy can co-occur with bipolar,
depressive, and anxiety disorders, and in rare
cases with schizophrenia
• Increased body mass index or obesity
• sleep apnea should be considered
Narcolepsy and Cataplexy are common
in Dogs
Causes
Hereditary in Labrador retrievers, poodles,
dachshunds, and Doberman pinschers
Possible immune system involvement
Nerve disorder
Idiopathic (unknown)
What are the causes of narcolepsy?
- narcolepsy is a rare disorder occurring
in less than 1% of people
- actual cause is unknown, may be a
biochemical imbalance
- possibly a genetic predisposition
What is the best treatment for
narcolepsy?
- no cure
- stimulants help prevent daytime
sleepiness
- drugs to prevent the onset of REM
sleep
- leading a lifestyle which allows for a
regular sleep-wake cycle including
daytime naps
Treating hypersomnia
•
Avoidancy of Alcohol and Caffeine
•
•
•
•
•
•
•
•
•
First line treatment : Modafinil
Traditional psychostimulants : Amphetamines
In Narcolepsy : REM sleep suppressing drugs ( Antidepressants )
Used for cataplexy
Imipramine Protryptiline
SSRIs
Sodium Oxorbate reducing cataplexy
Psychological counseling , Sheduled naps lifestyle adjustment ,
Modafinil ( Provigil)
a putative central alpha 1 adrenergic agonist, in idiopathic
hypersomnia and narcolepsy.
• Sleep attacks and drowsiness were significantly decreased
• Modafinil has an excellent benefit/risk ratio in idiopathic
hypersomnia
•
When cataplectic episodes were not totally suppressed the
association of a low dose of Clomipramine was successful in
improving them.
• Tablet 200 mg
pregnancy category C
Children less than 30 kg: 200-340 mg once
daily
Children more than 30 kg: 300-425 mg
Armodafinil
• Armodafinil is a FDA approved drug that is a
purer version of the active ingredient in Modafinil.
Alcover
• Sodium oxybate is the sodium salt ofγhydroxybutyric acid (GHB)
• alcohol withdrawal and dependence
•
•
•
•
•
•
•
Clarithromicine
Concerta
Dextroamphetamine
Flumazinel
Gluten Free Diet
Levothyroxine
Melatonin